A model incorporating sST2 and NT-proBNP was shown to outperform a model based on established MACE risk factors alone in stratifying risk of MACEs in a group of CHD patients.
No takes yet. Share an insight, caveat, or question.
Bai et al. (2020) studied this question.
Synapse has enriched 5 related papers. Consider them for comparative context: